Here We Go Again…Repeated Endovascular Treatment!
[et_pb_section fb_built="1" admin_label="section" _builder_version="3.0.47"][et_pb_row…
Newest ESO Certified Stroke Centre
[et_pb_section fb_built="1" _builder_version="3.19.7"][et_pb_row…
ESJ Comment: Selective serotonin reuptake inhibitors and risk of ICH
[et_pb_section fb_built="1" _builder_version="3.0.47"][et_pb_row…
FESO Interview with Alastair Webb
[et_pb_section fb_built="1" _builder_version="3.19.4"][et_pb_row…
Public Relations Committee
ESO PR Committee is responsible for the ESO member monthly newsletter
Stop it right now!
[et_pb_section fb_built="1" _builder_version="3.19.4"][et_pb_row…
ESO Department to Department Visit Report by Julie Haesebaert
[et_pb_section fb_built="1" _builder_version="3.0.47"][et_pb_row…
European Stroke Journal Comment
The development of carotid artery stenting (CAS) has changed the clinical practice, being the procedure as effective as CEA in preventing stroke recurrence or TIA after the post-procedural period1